0000000001107950

AUTHOR

Konstantinos Kontodimas

0000-0001-9593-505x

showing 2 related works from this author

The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.

2021

Significance: It is estimated that close to 50 million cases of sepsis result in over 11 million annual fatalities worldwide. The pathognomonic feature of sepsis is a dysregulated inflammatory response arising from viral, bacterial, or fungal infections. Immune recognition of pathogen-associated molecular patterns is a hallmark of the host immune defense to combat microbes and to prevent the progression to sepsis. Mitochondrial antiviral signaling protein (MAVS) is a ubiquitous adaptor protein located at the outer mitochondrial membrane, which is activated by the cytosolic pattern recognition receptors, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation associated gene 5 (M…

PhysiologyClinical BiochemistryBiologyBiochemistrySepsisImmune systemInterferonSepsismedicineAnimalsHumansMolecular BiologyGeneral Environmental ScienceMitochondrial antiviral-signaling proteinAdaptor Proteins Signal TransducingImmune EvasionLGP2Pattern recognition receptorSignal transducing adaptor proteinMDA5Cell Biologymedicine.diseaseForum Review ArticlesVirus DiseasesImmunologyHost-Pathogen InteractionsGeneral Earth and Planetary Sciencesmedicine.drugSignal TransductionAntioxidantsredox signaling
researchProduct

Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19

2021

The SARS-CoV-2 virus is causing devastating morbidity and mortality worldwide. Nanomedicine approaches have a high potential to enhance conventional diagnostics, drugs and vaccines. In fact, lipid nanoparticle/mRNA vaccines are already widely used to protect from COVID-19. In this review, we present an overview of the taxonomy, structure, variants of concern, epidemiology, pathophysiology and detection methods of SARS-CoV-2. The efforts of repurposing, tailoring, and adapting pre-existing medications to battle COVID-19 and the state of vaccine developments are presented. Next, we discuss the broad concepts and limitations of how nanomedicine could address the COVID-19 threat. Nanomaterials …

DrugMedicine (General)Coronavirus disease 2019 (COVID-19)nanotechnologyComputer scienceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectDiagnostic testNanotechnologySARS-CoV-2 virusReviewGeneral Medicineacute respiratory distress syndromesepsisdrug delivery systemsR5-920vaccineMedicineNanomedicineInorganic materialsRepurposingmedia_commonAir filterFrontiers in Medicine
researchProduct